Somani, A. .; Ibrahim, S. .; Tassavor, M. .; Yoo, J.; Farberg, A. Use of the 40-Gene Expression Profile (40-GEP) Test in Medicare-Eligible Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs. J of Skin 2024, 8, s336.